Investment analysts at StockNews.com initiated coverage on shares of USD Partners (NYSE:USDP – Get Free Report) in a report issued on Monday. The brokerage set a “hold” rating on the transportation company’s stock.
USD Partners Stock Performance
USDP opened at $0.12 on Monday. The business’s 50-day simple moving average is $0.15 and its 200 day simple moving average is $0.21. USD Partners has a 52-week low of $0.05 and a 52-week high of $3.30. The firm has a market capitalization of $4.05 million, a PE ratio of 0.22 and a beta of 1.26.
USD Partners (NYSE:USDP – Get Free Report) last posted its quarterly earnings results on Monday, March 11th. The transportation company reported ($0.17) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.13). The business had revenue of $11.18 million for the quarter.
About USD Partners
USD Partners LP acquires, develops, and operates midstream infrastructure assets and logistics solutions for crude oil, biofuels, and other energy-related products in the United States and Canada. It operates through two segments, Terminalling Services and Fleet Services. The Terminalling Services segment owns and operates Hardisty terminal, an origination terminal for loading various grades of Canadian crude oil onto railcars for transportation to end markets; Stroud terminal, a crude oil destination terminal, which is used to facilitate rail-to-pipeline shipments of crude oil located in Stroud, Oklahoma; Casper terminal, a crude oil storage, blending, and railcar loading terminal located in Casper, Wyoming; and West Colton Terminal, an unit train-capable destination terminals that trans load approximately 13,000 barrels per day ethanol and renewable diesel received by rail from producers onto trucks.
Read More
- Five stocks we like better than USD Partners
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Hilton Demonstrates Asset Light is Right for Investors
- The 3 Best Blue-Chip Stocks to Buy Now
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for USD Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USD Partners and related companies with MarketBeat.com's FREE daily email newsletter.